Former blockchain skeptic David Rubenstein discloses investments in crypto companies
The Carlyle Group co-founder also spoke on the regulatory landscape, saying that he does not anticipate excessive regulation from the...
The Carlyle Group co-founder also spoke on the regulatory landscape, saying that he does not anticipate excessive regulation from the...
The public was invited to comment on whether the regulators should use the term “crypto asset” instead of “digital asset"...
Cryptocurrency’s real-world utility is growing, users are increasing, and plans are proceeding apace — despite events that have provoked some...
“No matter the cause, this is an absolutely horrible idea and you should walk this back immediately,” said Adam Cochran,...
The total crypto market capitalization dropped by 6.9% in one week, while derivatives metrics reflect increasing demand for bearish bets.
The Bitcoin price prediction reveals that BTC is yet to gain strength above the moving averages as the coin moves...
The launch of El Salvador’s bitcoin bonds, issued to finance part of the construction of the Bitcoin City in the...
Precious metal markets have shuddered during the last few weeks, as gold’s price per ounce nears a six-week low hovering...
On August 31, 2022, Ethereum Classic’s hashrate reached another all-time high (ATH) this year at block height 15,850,811. Ethereum Classic’s...
Solana was back in the red on Thursday, as the token fell towards a three-month low in today’s session. The...
The addition of Jill Sommers followed former CFTC commissioner Mark Wetjen becoming FTX US' head of policy and regulatory strategy...
Suspension of withdrawals on Celsius custody contradicts the plain language of the firm’s terms of use, a group of disgruntled...
Meitu was one among many public companies that purchased Bitcoin to hold as a treasury reserve during the peak of...
ADA prints modest upside moves that may run out of steam due to weak technicals and macro factors.
The firm seeks to use Triall's medical software to create immutable clinical trial records.